Patients with NASH have increased serum DPP-4 activity compared to controls and also increased hepatic staining of DPP-4 that correlated with hepatic steatosis and histopathological grade of NASH but were not correlated to each other [190]. This evidence concerns the gene DPP4 and metabolic dysfunction-associated steatohepatitis.